STOCK TITAN
  1. Home
  2. Sec-filings
  3. TELA
  4. [Form 4] TELA Bio, Inc. Insider Trading Activity

TELA Bio (TELA) director Paul Thomas receives RSU and option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TELA Bio director Paul Thomas reported new equity awards. On June 9, 2026, he received two grants of Common Stock: 11,675 restricted stock units that vest in three equal annual installments starting June 9, 2027, and 11,925 restricted stock units that vest by the earlier of June 9, 2027, the next annual stockholder meeting, or a Change in Control, in each case subject to continued service.

He also received stock options for 17,335 and 17,550 shares of Common Stock at an exercise price of $0.935 per share, expiring on June 9, 2036. One option grant vests in 36 equal monthly installments beginning on June 9, 2026, and the other vests on the earlier of June 9, 2027, the next annual meeting, or a Change in Control, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider THOMAS PAUL
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 17,550 $0.00 --
Grant/Award Stock Option (Right to Buy) 17,335 $0.00 --
Grant/Award Common Stock 11,925 $0.00 --
Grant/Award Common Stock 11,675 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 17,550 shares (Direct, null); Common Stock — 11,925 shares (Direct, null)
Footnotes (1)
  1. These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date. These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date. The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
RSU grant 1 11,675 shares of Common Stock Restricted stock units vesting in three equal annual installments from June 9, 2027
RSU grant 2 11,925 shares of Common Stock Restricted stock units vesting by earlier of June 9, 2027, next annual meeting, or Change in Control
Option grant 1 size 17,335 options Stock options over Common Stock at $0.935 exercise price
Option grant 2 size 17,550 options Stock options over Common Stock at $0.935 exercise price
Option strike price $0.935 per share Exercise price for both new stock option grants
Option expiration June 9, 2036 Expiration date for both stock option grants
Shares held after first RSU grant 23,600 shares Total Common Stock following the 11,675-share award
Shares held after second RSU grant 11,925 shares Total Common Stock related to the 11,925-share award
restricted stock units financial
"These restricted stock units will vest in three equal annual installments..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Change in Control financial
"the occurrence of a Change in Control (as defined in the Issuer's Amended..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Amended and Restated 2019 Equity Incentive Plan financial
"as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan..."
stock option financial
"The option vests in 36 equal monthly installments on each monthly anniversary..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"in each case subject to the Reporting Person's continued service through the applicable vesting date."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
THOMAS PAUL
(Last)(First)(Middle)
C/O TELA BIO, INC.
1 GREAT VALLEY PARKWAY, SUITE 24
(Street)
MALVERN PENNSYLVANIA 19355
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/09/2026A11,925(1)A$011,925D
Common Stock06/09/2026A11,675(2)A$023,600D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$0.93506/09/2026A17,550 (3)06/09/2036Common Stock17,550$017,550D
Stock Option (Right to Buy)$0.93506/09/2026A17,335 (4)06/09/2036Common Stock17,335$017,335D
Explanation of Responses:
1. These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.
2. These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
3. The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date.
4. The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
/s/ Megan Smeykal, Attorney-in-Fact06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did TELA (TELA) director Paul Thomas receive?

Paul Thomas received two restricted stock unit grants and two stock option grants in TELA Bio Common Stock. The RSUs cover 11,675 and 11,925 shares, while the options cover 17,335 and 17,550 shares at a strike price of $0.935 per share.

How do Paul Thomas’s new RSU awards at TELA (TELA) vest?

One RSU award of 11,675 shares vests in three equal annual installments starting June 9, 2027. The 11,925-share RSU award vests by the earlier of June 9, 2027, the next annual stockholder meeting, or a Change in Control, subject to continued service.

What are the terms of Paul Thomas’s new TELA (TELA) stock options?

Thomas received stock options over 17,335 and 17,550 TELA Bio shares at an exercise price of $0.935 per share. Both option grants expire on June 9, 2036, with one vesting monthly over 36 months and the other vesting on specified earlier events.

Are Paul Thomas’s TELA (TELA) Form 4 transactions open-market purchases?

No, the Form 4 transactions reflect equity awards, not open-market purchases. All four entries are coded as grants or awards, with a per-share transaction price of $0.0000, indicating compensation-related grants rather than discretionary buying in the public market.

What service conditions apply to Paul Thomas’s new TELA (TELA) awards?

All RSU and option awards require Paul Thomas’s continued service through each vesting date. Some vest over time in installments, while others vest on the earlier of June 9, 2027, the next annual meeting, or a qualifying Change in Control event.